arXiv (All)
open access
Beyond Drug Discovery: The Nanotechnology Molecular Optimization (NMO) Benchmark
Generative molecular design is shaped by simple proxy benchmarks for drug-like properties and models pretrained on large pharmaceutical datasets. This combination yields strong benchmark metrics but limits transferability to domains structurally distinct from drug discovery. To overcome this limitat
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Docking and Machine Learning approaches to explore new scaffolds for molecules of therapeutic interest. (Approches de docking et de Machine Learning pour l'exploration de nouveaux « scaffolds » lors de la recherche de molécules d'intérêt thérapeutique).#489534
- Small Molecule Optimization with Large Language Models#986765
- Ensemble-Conditioned Molecular Design#1084965
- Swarm Intelligence in Drug Discovery Applications: Unlocking Deeper Insights on the Identification and Optimization of Potential Drug Candidates.#320545
- Artificial Intelligence in Pharmaceutical Care: Transforming Drug Discovery, Development, and Patient-care Delivery.#421025
Record · ID 1105098
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive